Delivery Order SPE2DB22D3004-SPE2DB25FRW09
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $51,605.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price, non-set-aside contract was awarded on July 10, 2025, with an ultimate completion date of July 31, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents valued at $20,642.20, with an ultimate completion date of August 26, 2025. This non-set-aside competitive award is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $52,650.50 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on October 20, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,158.88 on August 8, 2025, for Varivax vaccine with diluents to be delivered to the company's facility in Conshohocken, Pennsylvania, with completion targeted for August 29, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award authority. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,127.68 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 18, 2025, with completion expected by September 9, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract supporting federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,159.03 on August 12, 2025, for the supply of Varivax vaccine with diluents. The order, which is non-competitive and carries a firm fixed price, is scheduled for completion by September 3, 2025, with performance to take place at the contractor's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $2,092.38 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on May 30, 2025, with an ultimate completion date of June 23, 2025. This firm fixed-price contract represents a non-competitive set-aside award and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $7,224.77 firm fixed-price delivery order from the Defense Logistics Agency for Varivax vaccine with diluents, with an ultimate completion date of October 7, 2025. This is a non-set-aside, competitively awarded contract to be performed at the company's Conshohocken facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $2,085.12 to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRW09Delivery Order
The Defense Logistics Agency awarded a $2,064.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for Varivax vaccine with diluents on August 6, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and serves as a critical federal vendor for medical procurement needs across military and veteran healthcare systems. As a prime contractor under the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceutical products and medical supplies, including vaccines, specialty medications, brand-name and generic drugs, and specialized medical devices. The company's consistent receipt of competitively awarded delivery orders across multiple therapeutic domains demonstrates its capability to meet federal procurement requirements and its strategic role in supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/6/25 |